SCHEMBL6328024

SCHEMBL6328024

CC(C)(C)N(O)c1ccc(C(=O)Nc2cccs2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.57
NAMPT P43490 1/20 0.44
GAA P10253 11/20 0.42
MEN1 O00255 8/20 0.42
KMT2A Q03164 8/20 0.42
HSD17B10 Q99714 7/20 0.42
BCHE P06276 1/20 0.41
MAPT P10636 8/20 0.40
RAB9A P51151 6/20 0.40
ALOX15 P16050 5/20 0.40
HTT P42858 5/20 0.40
TP53 P04637 4/20 0.40
NPC1 O15118 4/20 0.40
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
GFER P55789 1/20 0.40
ALDH1A1 P00352 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
USP2 O75604 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6328266 0.76 NPC1 (0.64) GBA1MEN1KMT2AHSD17B10MAPT
SCHEMBL3559655 0.75 MEN1 (0.60) GBA1NAMPTGAAMEN1KMT2A
SCHEMBL6328469 0.74 GLA (0.45) GAAMEN1KMT2ARAB9ANPC1
SCHEMBL20389106 0.74 MEN1 (0.55) GBA1NAMPTGAAMEN1KMT2A
SCHEMBL6327994 0.74 GBA1 (0.50) GBA1NAMPTGAAMEN1KMT2A
SCHEMBL20379964 0.72 MAPT (0.63) GBA1GAAMEN1KMT2AMAPT
SCHEMBL3914463 0.72 NAMPT (0.63) GBA1NAMPTGAAMEN1KMT2A
SCHEMBL6331771 0.72 SMN1; SMN2 (0.58) MEN1KMT2AMAPTRAB9AHTT
SCHEMBL29952373 0.72 GBA1 (0.53) GBA1NAMPTGAAMEN1KMT2A
SCHEMBL3891666 0.71 ALOX5 (0.60) GBA1GAAMEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949654-B2 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses SAM-SUNG ELECTRONICS CO., LTD. (KR) 2005-09-27 US claimed
US-6949654-B2 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses SAM-SUNG ELECTRONICS CO., LTD. (KR) 2005-09-27 US disclosed
US-20030225087-A1 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses SAM-SUNG ELECTRONICS CO., LTD. (KR) 2003-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225087-A1 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses SOD1, LPO, BAD GBA1 177/4885NAMPT 827/4885GAA 464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.